Report ID: 10307122 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
The global parkinson’s disease treatment market is expected to witness significant growth over the forecast period. Increasing prevalence of Parkinson's disease is expected to accelerate the growth of this industry in near future. Additionally, combination treatments which aids in prolonged action of unremitting dopaminergic stimulation medicines, gene therapy and neural transplantation is anticipated to boost the industry growth.
Parkinson’s is a neurodegenerative disease which primarily affects the human brain parts, making it difficult for the person to function or perform daily routine. People suffering from Parkinson’s cannot produce enough dopamine, which leads to stiffness, tremors, walking problems among others. This disease can become severe if not treated on time. This severity can result in increasing demand for Parkinson’s disease treatment
Scope of the Report
The Parkinson’s disease drugs market has been segmented by mechanism of action and geography. By mechanism of action, the market studied is segmented into dopamine agonists, anticholinergic, MAO-B inhibitors, amantadine, carbidopa-levodopa, COMT inhibitors, and others.
Market Segmentation
Parkinson’s disease Treatment Market, By Type
*Dopamine Agonists
*Levodopa
*Glutamate Antagonist
*Apomorphine
*COMT Inhibitors Anticholinergics
*MAO-B Inhibitors
By Application
*Hospitals
*Healthcare Institutes
*Others
By Regional Ananlysis
North America
*U.S.
*Canada
Europe
*Germany
*UK
*France
*Italy
*Spain
*Belgium
*Russia
*Netherlands
*Rest of Europe
Asia-Pacific
*China
*India
*Japan
*Korea
*Singapore
*Malaysia
*Indonesia
*Thailand
*Philippines
*Rest of Asia-Pacific
Latin America
*Brazil
*Mexico
*Argentina
*Rest of LATAM
Middle East & Africa
*UAE
*Saudi Arabia
*South Africa
*Rest of MEA
Global Parkinson's Disease Treatment Market: Competitive Players
Some of the most important market players in the Parkinson’s disease treatment market are Salix Pharmaceuticals, GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Impax Laboratories, Inc., Orion Corporation, Novartis AG, Par Pharmaceutical, Mylan N.V., Daiichi Sankyo, Cipla Inc., Wockhardt Limited, and Apotex Inc., among others.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10307122 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
